Active-ingredient Dossier
Fentanyl Citrate
Active-ingredient Dossier for Fentanyl Citrate (opioid analgesic). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: FENTANYL
- Brand: Fentanyl GH Solution
- Brand: SUBLIMAZE
- Therapeutic area: Pain & Anaesthesia
- Therapeutic area: Pain Management
What is
Fentanyl Citrate Fentanyl Citrate is an opioid analgesic.
Australian brands containing
Fentanyl Citrate — ABSTRAL — ACTIQ — FENTORA — FENTANYL — Fentanyl GH Solution — FENTANYL JUNO — SUBLIMAZE
Therapeutic areas
Fentanyl Citrate is registered in two therapeutic areas: Pain & Anaesthesia, with 4 brands, and Oncology, with 3 brands.
Sponsor landscape
Six sponsors market Fentanyl Citrate in Australia: Anspec, A Menarini, Medsurge Pharma, Generic Health, Juno Pharmaceuticals, and Piramal Critical Care.
PBS and regulatory activity
Three brands containing Fentanyl Citrate are PBS-listed, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is dated 1 July 2017, and the latest AusPAR is dated 12 August 2013.